The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IκB kinase (IKK)
Abstract
Autophagic and proteasomal proteolysis are two major pathways for degradation of cellular constituents. Current models suggest that autophagy is responsible for the nonselective bulk degradation of long-lived proteins and organelles while the proteasome specifically degrades short-lived proteins including misfolded proteins caused by the absence of Hsp90 function. Here, we show that the IkappaB kinase (IKK), an essential activator of NF-kappaB, is selectively degraded by autophagy when Hsp90 is inhibited by geldanamycin (GA), a specific Hsp90 inhibitor showing highly effective anti-tumor activity. We find that in this case inactivation of ubiquitination or proteasome fails to block IKK degradation. However, inhibition of autophagy by an autophagy inhibitor or knockout of Atg5, a key component of the autophagy pathway, significantly rescues IKK from GA-induced degradation. These findings provide the first evidence that an Hsp90 client may be degraded by a mechanism different from the proteasome pathway and establish a molecular link among Hsp90, NF-kappaB and autophagy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In neuronal cells pharmacological inhibition of proteosomal activity up-regulates lysosomal enzymes, whereas lysosomal disruptors inhibit both lysosomal and proteosomal degradation.”
From A Unique Carboxyl-terminal Insert Domain in the Hematopoietic-specific, GTPase-deficient Rho GTPase RhoH Regulates Post-translational Processing (2013) · cites this paper as [55]
In the citing paper
“In neuronal cells pharmacological inhibition of proteosomal activity up-regulates lysosomal enzymes, whereas lysosomal disruptors inhibit both lysosomal and proteosomal degradation.”
From A Unique Carboxyl-terminal Insert Domain in the Hematopoietic-specific, GTPase-deficient Rho GTPase RhoH Regulates Post-translational Processing (2013) · cites this paper as [55]
In the citing paper
“Furthermore, inhibition of lysosomal or proteosomal pathways both lead to up-regulation of Hsc70 levels and induced chaperone-mediated autophagy (39, 40, 54 -57).”
From A Unique Carboxyl-terminal Insert Domain in the Hematopoietic-specific, GTPase-deficient Rho GTPase RhoH Regulates Post-translational Processing (2013) · cites this paper as [55]
Citations
Cites
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Research works printed but not linked: 28
- Levine B, Klionsky DJ . Development by self-digestion molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6:463–477. · DOI
- Lodish H, Berk A, Matsudaira P, et al. Molecular Cell Biology. 5th Edition, New York: WH Freeman and Company. 2004: 59.
- Dai C, Whitesell L . HSP90: a rising star on the horizon of anticancer targets. Future Oncol 2005; 1:529–540. · DOI
- Zhang H, Burrows F . Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med 2004; 82:488–499.
- Whitesell L, Mimnaugh EG, De Costa B, Myers CE, Neckers LM . Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sc USA 1994; 91:8324–8328. · DOI · Paper page
- Majeski AE, Dice JF . Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell 2004; 36:2435–2444. · DOI
- Chen G, Cao P, Goeddel DV . TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 2002; 9:401–410. · DOI
- Xiao G, Rabson A, Young W, Qing G, Qu Z . Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 2006; 17:281–293. · DOI
- Xiao G, Harhaj EW, Sun SC . Domain-specific interaction with the I kappa B kinase (IKK) regulatory subunit IKK gamma is an essential step in tax-mediated activation of IKK. J Biol Chem 2000; 275:34060–34067. · DOI
- Qing G, Qu Z, Xiao G . Regulation of NF-kappaB2 p100 processing by its cis-acting domain. J Biol Chem 2004; 280:18–27. · DOI
- Harhaj EW, Good L, Xiao G, et al. Somatic mutagenesis studies of NF-kappaB signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappaB activation by T-cell costimulatory signals and HTLV-I Tax protein. Oncogene 2000; 19:1448–1456. · DOI
- Qing G, Qu Z, Xiao G . Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100. J Biol Chem 2005; 280:40578–40582. · DOI
- Qu Z, Qing G, Rabson A, Xiao G . Tax deregulation of NF-kappaB2 p100 processing involves both beta-TrCP-dependent and -independent mechanisms. J Biol Chem 2004; 279:44563–44572. · DOI
- Xiao G, Harhaj EW, Sun SC . NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 2001; 8:401–409. · DOI
- Xiao G, Civijic ME, Fong A, et al. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J 2001; 20:6805–6815. · DOI
- Qing G, Xiao G . Essential role of IkappaB kinase alpha in the constitutive processing of NF-kappaB2 p100. J Biol Chem 2005; 280:9765–9768. · DOI
- Basso AD, Solit DB, Chiosis G, et al. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J Biol Chem 2002; 277:39858–39866. · DOI · Paper page
- Broemer M, Krappmann D, Scheidereit C . Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation. Oncogene 2004; 23:5378–5386. · DOI
- Chowdary DR, Dermody JJ, Jha KK, Ozer HL . Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol Cell Biol 1994; 14:1997–2003. · DOI
- Orlowski M, Wilk S . Ubiquitin-independent proteolytic functions of the proteasome. Arch Biochem Biophys 2003; 415:1–5. · DOI
- Edinger AL, Thompson CB . Defective autophagy leads to cancer. Cancer Cell 2003; 4:442–424. · DOI
- Mizushima N . The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ 2005; 12 Suppl 2:1535–1541. · DOI
- Shintani T, Klionsky DJ . Autophagy in health and disease: a double-edged sword. Science 2004; 306:990–995. · DOI
- Samari HR, Seglen PO . Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase. J Biol Chem 1998; 273:23758–23763. · DOI · Paper page
- Yu L, Wan F, Dutta S, et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci USA 2006; 103:4952–4957. · DOI
- Agarraberes FA, Dice JF . A molecular chaperone complex at the lysosomal membrane is required for protein translocation. J Cell Sci 2001; 114:2491–2499. · DOI
- Kondo Y, Kanzawa T, Sawaya R, Kondo S . The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726–734. · DOI
- Levine B, Yuan J . Autophagy in cell death: an innocent convict? J Clin Invest 2005; 115:2679–2688. · DOI
Cited by
Regulation of the aging process by autophagy.
Salminen, A., & Kaarniranta, K. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.03.004 · Cited by 270
HSP90 acts as a senomorphic target in senescent retinal pigmental epithelial cells
Chen, D.-D., Peng, X., Wang, Y., Jiang, M., Xue, M., Shang, G., Liu, X., Jia, X., Liu, B., Lu, Y., et al. (2021) · Aging · doi:10.18632/aging.203496 · Cited by 38
Troeger, A., Chae, H.-D., Senturk, M., Wood, J., & Williams, D. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.505727 · Cited by 15
Metadata
- Authors
- Qing, G., Yan, P., & Xiao, G.
- Venue
- Cell Research
- Published
- 2006-11
- Volume
- 16
- Issue
- 11
- Pages
- 895-901
- ISSN
- 1001-0602
- 1748-7838
- Cited by
- 140
- References
- 2
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review